Surprisingly, the authors further demonstrated that STEAP1 knockdown by siRNA reversed the sensitivity of LNCap prostate cancer cells to the apoptotic effects of paclitaxel and cabazitaxel [279]. The gene discussed is STEAP1; the disease is prostate carcinoma.